| Products and Services |
Categories |
They are a biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases. They are developing a portfolio of Nanobody-based therapeutic programmes in a number of major disease areas, including inflammation, thrombosis, oncology and Alzheimer’s disease. They have generated Nanobodies against more than 100 different disease targets and has characterized potent antagonists in vitro against 20 different targets. |
|
Fields marked as * are mandatory
|
|
| *Message |
|
| Contact Details |
Technologiepark 4
Ghent
9052
Belgium
Tel: 32-9261-06-32 |
|
| *Request
Type |
|
| *Email |
|
| *First
Name |
|
| *Last
Name |
|
| Address 1 |
|
| Address 2 |
|
| City |
|
| State |
|
| *Country |
|
| Zip |
|
| *Organization |
|
| *Telephone |
|
| Extension |
|
| Designation |
|
| Other |
|
|
Industry |
|
|
Other |
|
Preferred
Method Of
Contact |
If Other
Specify
|
|
|
